Physician profile
Donald Morando
NPI 1164477998
$260.46
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.56 · 2020: $41.88 · 2021: $86.50 · 2022: $23.65 · 2024: $80.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $80.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $80.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $40.83 | 2024 | |
| Currax Pharmaceuticals LLC | $39.52 | 2020-2021 | |
| Glaxosmithkline, LLC. | $26.93 | 2020-2021 | |
| Lilly USA, LLC | $23.65 | 2022 | |
| Abbott Laboratories | $22.77 | 2024 | Eterna |
| Takeda Pharmaceuticals U.S.A., INC. | $18.09 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $17.96 | 2021 | |
| Exact Sciences Corporation | $17.27 | 2024 | Cologuard Collection Kit |
| Amgen INC. | $15.11 | 2019 | |
| Amarin Pharma, INC. | $14.69 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $12.45 | 2019 | |
| Novo Nordisk INC | $11.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Morando listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.